Volitionrx limited announces pricing of $16.5 million underwritten public offering of common stock

Henderson, nev. , june 1, 2023 /prnewswire/ -- volitionrx limited (nyse american: vnrx) ("volition" or the "company"), a multi-national epigenetics company, announced today the pricing of an underwritten public offering of 13,000,000 shares of its common stock at a public offering price of $1.27 per share.
VNRX Ratings Summary
VNRX Quant Ranking